Wenke Jin

507 total citations · 1 hit paper
17 papers, 256 citations indexed

About

Wenke Jin is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Wenke Jin has authored 17 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Wenke Jin's work include Autophagy in Disease and Therapy (6 papers), Epigenetics and DNA Methylation (3 papers) and Protein Degradation and Inhibitors (3 papers). Wenke Jin is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Epigenetics and DNA Methylation (3 papers) and Protein Degradation and Inhibitors (3 papers). Wenke Jin collaborates with scholars based in China and Hong Kong. Wenke Jin's co-authors include Bo Liu, Lan Zhang, Leilei Fu, Lingjuan Zhu, Shiou Zhu, Liang Ouyang, Yi Chen, Haiyang Yu, Wei Liu and Yongqi Zhen and has published in prestigious journals such as Drug Discovery Today, Signal Transduction and Targeted Therapy and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Wenke Jin

16 papers receiving 256 citations

Hit Papers

2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenke Jin China 9 169 49 38 33 33 17 256
Caterina Bartolacci Italy 11 224 1.3× 20 0.4× 48 1.3× 78 2.4× 77 2.3× 15 345
Joo‐Yun Byun South Korea 8 228 1.3× 96 2.0× 22 0.6× 56 1.7× 31 0.9× 29 365
Ahmed Gaafar Ahmed Gaafar Egypt 9 129 0.8× 42 0.9× 24 0.6× 44 1.3× 22 0.7× 16 263
Maria Hoh United States 5 192 1.1× 125 2.6× 20 0.5× 47 1.4× 46 1.4× 7 283
Peipei Nie China 8 277 1.6× 51 1.0× 35 0.9× 71 2.2× 163 4.9× 8 400
Fayaz Malik India 4 135 0.8× 33 0.7× 22 0.6× 65 2.0× 76 2.3× 5 260
Chengcan Yang China 11 263 1.6× 38 0.8× 34 0.9× 74 2.2× 48 1.5× 14 368
Lilin Qian China 9 157 0.9× 30 0.6× 61 1.6× 41 1.2× 70 2.1× 17 253
Perry Dhaliwal India 2 251 1.5× 52 1.1× 39 1.0× 99 3.0× 66 2.0× 3 393
Trang Huyen Lai South Korea 11 194 1.1× 119 2.4× 22 0.6× 26 0.8× 93 2.8× 22 321

Countries citing papers authored by Wenke Jin

Since Specialization
Citations

This map shows the geographic impact of Wenke Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenke Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenke Jin more than expected).

Fields of papers citing papers by Wenke Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenke Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenke Jin. The network helps show where Wenke Jin may publish in the future.

Co-authorship network of co-authors of Wenke Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenke Jin. A scholar is included among the top collaborators of Wenke Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenke Jin. Wenke Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Shao, Yingying, Di Lu, Wenke Jin, et al.. (2025). Targeting LIF With Cyclovirobuxine D to Suppress Tumor Progression via LIF/p38MAPK/p62‐Modulated Mitophagy in Hepatocellular Carcinoma. MedComm. 6(6). e70227–e70227. 1 indexed citations
3.
Wang, Huiping, et al.. (2024). Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy. Drug Discovery Today. 29(10). 104155–104155. 2 indexed citations
4.
Li, Zixiang, Yingying Lu, Yongqi Zhen, et al.. (2024). Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis. Phytomedicine. 135. 156209–156209. 14 indexed citations
5.
Jin, Wenke, et al.. (2024). Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer. Acta Pharmaceutica Sinica B. 14(7). 2815–2853. 23 indexed citations
6.
Liu, Meiling, Guanhuier Wang, Wenke Jin, et al.. (2024). Poloxamer 188 washing of lipoaspirate improves fat graft survival: A comparative study in nude mice. Journal of Plastic Reconstructive & Aesthetic Surgery. 95. 357–367. 3 indexed citations
7.
Fu, Peng, Minru Liao, Wenke Jin, et al.. (2024). 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduction and Targeted Therapy. 9(1). 133–133. 51 indexed citations breakdown →
8.
Jin, Wenke, Jin Zhang, Xiya Chen, et al.. (2023). Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(4). 188916–188916. 3 indexed citations
9.
Wu, Lifeng, Wenke Jin, Haiyang Yu, & Bo Liu. (2023). Modulating autophagy to treat diseases: A revisited review on in silico methods. Journal of Advanced Research. 58. 175–191. 9 indexed citations
10.
Jin, Wenke, et al.. (2023). Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma. Journal of Cancer Research and Clinical Oncology. 149(18). 16691–16703. 3 indexed citations
11.
Xiao, Yao, Wenke Jin, Wen Li Peng, et al.. (2022). Synthesis, antiproliferative and anti-MDR activities of lathyrane diterpene derivatives based on configuration inversion strategy. Bioorganic Chemistry. 131. 106329–106329. 6 indexed citations
12.
Li, Zixiang, et al.. (2022). Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds. Drug Discovery Today. 27(8). 2373–2385. 11 indexed citations
13.
Liu, Wei, Wenke Jin, Shiou Zhu, Yi Chen, & Bo Liu. (2021). Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis. Drug Discovery Today. 27(2). 612–625. 33 indexed citations
14.
Jin, Wenke, et al.. (2021). Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions. Drug Discovery Today. 27(1). 246–256. 28 indexed citations
15.
Fu, Leilei, Wenke Jin, Lingjuan Zhu, et al.. (2021). Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions. Acta Pharmaceutica Sinica B. 12(2). 532–557. 49 indexed citations
16.
Jin, Wenke, et al.. (2021). ESD-PCM: Constructing Reliable Super Dense Phase Change Memory Under Write Disturbance. 39. 1–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026